Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of ARCT-032 in Healthy Adult Subjects and Adults With Cystic Fibrosis. [Phase 1]

View source ↗

Summary

This clinical trial update reports safety, tolerability, and pharmacokinetics data for ARCT-032 in healthy adults and adults with cystic fibrosis from a Phase 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ARCT-032

Snippet

Sponsor: Arcturus Therapeutics, Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED